133 related articles for article (PubMed ID: 1325797)
1. N-terminal truncation of salmon calcitonin leads to calcitonin antagonists. Structure activity relationship of N-terminally truncated salmon calcitonin fragments in vitro and in vivo.
Feyen JH; Cardinaux F; Gamse R; Bruns C; Azria M; Trechsel U
Biochem Biophys Res Commun; 1992 Aug; 187(1):8-13. PubMed ID: 1325797
[TBL] [Abstract][Full Text] [Related]
2. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
[TBL] [Abstract][Full Text] [Related]
3. Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors.
Hilton JM; Dowton M; Houssami S; Sexton PM
J Endocrinol; 2000 Jul; 166(1):213-26. PubMed ID: 10856900
[TBL] [Abstract][Full Text] [Related]
4. Structure/function relationships of calcitonin analogues as agonists, antagonists, or inverse agonists in a constitutively activated receptor cell system.
Pozvek G; Hilton JM; Quiza M; Houssami S; Sexton PM
Mol Pharmacol; 1997 Apr; 51(4):658-65. PubMed ID: 9106632
[TBL] [Abstract][Full Text] [Related]
5. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions.
Stroop SD; Nakamuta H; Kuestner RE; Moore EE; Epand RM
Endocrinology; 1996 Nov; 137(11):4752-6. PubMed ID: 8895343
[TBL] [Abstract][Full Text] [Related]
6. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
[TBL] [Abstract][Full Text] [Related]
7. Insights into interactions between the alpha-helical region of the salmon calcitonin antagonists and the human calcitonin receptor using photoaffinity labeling.
Pham V; Dong M; Wade JD; Miller LJ; Morton CJ; Ng HL; Parker MW; Sexton PM
J Biol Chem; 2005 Aug; 280(31):28610-22. PubMed ID: 15929987
[TBL] [Abstract][Full Text] [Related]
8. des-Ser2 salmon calcitonin: a biologically potent synthetic analog.
Schwartz KE; Orlowski RC; Marcus R
Endocrinology; 1981 Mar; 108(3):831-5. PubMed ID: 6257497
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin inhibits phosphate uptake in opossum kidney cells stably transfected with a porcine calcitonin receptor.
Muff R; Kaufmann M; Born W; Fischer JA
Endocrinology; 1994 Mar; 134(3):1593-6. PubMed ID: 8119203
[TBL] [Abstract][Full Text] [Related]
10. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.
Epand RM; Epand RF; Stafford AR; Orlowski RC
J Med Chem; 1988 Aug; 31(8):1595-8. PubMed ID: 3397998
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin and calcitonin gene-related peptide interact with the same receptor in cultured LLC-PK1 kidney cells.
Wohlwend A; Malmström K; Henke H; Murer H; Vassalli JD; Fischer JA
Biochem Biophys Res Commun; 1985 Sep; 131(2):537-42. PubMed ID: 2996513
[TBL] [Abstract][Full Text] [Related]
12. A chimeric analog of human and salmon calcitonin eliminates antigenicity and reduces gastrointestinal disturbances.
Kozono T; Hirata M; Endo K; Satoh K; Takanashi H; Miyauchi T; Fukushima N; Kumagai E; Abe S; Matsuda E
Endocrinology; 1992 Dec; 131(6):2885-90. PubMed ID: 1280207
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin stimulates plasminogen activator in porcine renal tubular cells: LLC-PK1.
Dayer JM; Vassalli JD; Bobbitt JL; Hull RN; Reich E; Krane SM
J Cell Biol; 1981 Oct; 91(1):195-200. PubMed ID: 6271791
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants of salmon calcitonin bioactivity: the role of the Leu-based amphipathic alpha-helix.
Andreotti G; Méndez BL; Amodeo P; Morelli MA; Nakamuta H; Motta A
J Biol Chem; 2006 Aug; 281(34):24193-203. PubMed ID: 16766525
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
Samura A; Wada S; Suda S; Iitaka M; Katayama S
Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin is a physiological inhibitor of prolactin secretion in ovariectomized female rats.
Shah GV; Pedchenko V; Stanley S; Li Z; Samson WK
Endocrinology; 1996 May; 137(5):1814-22. PubMed ID: 8612519
[TBL] [Abstract][Full Text] [Related]
17. Biologically active salmon calcitonin-like peptide is present in rat brain.
Sexton PM; Hilton JM
Brain Res; 1992 Nov; 596(1-2):279-84. PubMed ID: 1467988
[TBL] [Abstract][Full Text] [Related]
18. Biological properties of salmon calcitonin IV.
Schecroun N; Pidoux E; Horne WC; Hernandez-Lagunas L; Baron R; Cressent M
J Bone Miner Res; 1999 Aug; 14(8):1425-31. PubMed ID: 10457276
[TBL] [Abstract][Full Text] [Related]
19. A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats.
Yates AJ; Gutierrez GE; Garrett IR; Mencel JJ; Nuss GW; Schreiber AB; Mundy GR
Endocrinology; 1990 Jun; 126(6):2845-9. PubMed ID: 2351097
[TBL] [Abstract][Full Text] [Related]
20. Effects of amylin and salmon calcitonin on beta-endorphin-induced growth hormone and prolactin secretion in the rat.
Pagani F; Netti C; Guidobono F; Lattuada N; Ticozzi C; Sibilia V
Neuroendocrinology; 1998 Sep; 68(3):220-8. PubMed ID: 9734007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
